Pharmacology
 |
|
24 may 2019 14:01:08 |
| Genetics and adverse events with irinotecan treatment: what do we know? (Pharmacogenomics) |
|
Tweet Pharmacogenomics, Volume 20, Issue 6, Page 393-395, April 2019. |
| 128 viewsCategory: Genomics, Pharmacology |
 CYP2C19 genotype, physician prescribing pattern, and risk for long QT on serotonin selective reuptake inhibitors (Pharmacogenomics)Genomic profiling and predicting treatment response in acute myeloid leukemia (Pharmacogenomics) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
